The Office of Management and Budget has proposed a government-wide regulation that would fundamentally change how federal research grants are awarded, and Congress is now weighing whether to block it. Buried in the sweeping rewrite of federal grant rules is a provision that would make peer review recommendations merely “advisory” and prohibit agencies from “routinely deferring to” them.
That language has alarmed scientists and research advocates, who argue it would invert a system that has long kept politics out of funding decisions. Under the current process, peer reviewers—experts in their fields—evaluate the scientific merit of proposals, and agency leaders generally follow those assessments. The OMB rule would allow political appointees to disregard that advice more easily, potentially steering grants toward politically favored projects.
The proposal also introduces vague criteria—such as “national interest,” “Gold Standard Science,” and “anti-American values”—that critics say give officials broad and subjective discretion to pick winners and losers. “Whatever one’s political affiliation, no administration should possess the power to decide which scientific questions are acceptable using standards this vague,” one congressional aide said.
Congressional action is already underway. A Senate GOP spending bill would block the OMB rule from being implemented, although the measure has stalled amid broader budget negotiations. Lawmakers are considering adding language to a continuing resolution that would prohibit funds from being used to finalize or enforce the regulation.
The stakes extend beyond universities. Federal research underpins discoveries that lead to new medicines, strengthen national security, and drive economic growth. The biotechnology and pharmaceutical sectors rely heavily on knowledge generated through federally funded basic research. If political interference weakens that pipeline, patients, workers, and the economy ultimately suffer.
Peer review is imperfect, but it exists for an indispensable reason: evaluating research proposals requires deep expertise. Determining whether an experiment is rigorous, whether its methods can answer the question posed, and whether its conclusions are meaningful cannot be reduced to a political checklist. At the National Institutes of Health, scientists spend thousands of hours reviewing proposals, and similar systems operate at the National Science Foundation and the Department of Energy.
The OMB rule would also broaden agencies’ ability to terminate existing grants if they are deemed no longer to serve administration priorities. That could leave labs with hired staff and ongoing projects suddenly defunded after an election, making long-term research impossible. “A cancer study should not be funded or rejected according to whether a political appointee approves of its possible findings,” said a former NIH official.
Critics warn that political review would reward caution and conformity. Scientists would begin asking not which questions are most important, but which are least likely to offend the administration. Young investigators would learn that intellectual independence carries financial risk, and universities might discourage research in politically sensitive fields.
Congress should preserve statutory protections for peer review and require agencies to disclose and justify any decision that contradicts expert recommendations. As one policy expert noted, “Political officials must remain accountable for departures from scientific merit; such decisions should never occur behind closed doors.”
The issue should not divide Republicans and Democrats. Every administration is temporary, and a power created for one president will be inherited by the next. Lawmakers who trust today’s appointees should ask whether they would willingly give the same authority to officials from the opposing party. The answer, many say, should be no.
